Sign inJoin waitlistJoin the waitlist

Rajiv Panikkar

Is the Chair of the Geisinger Cancer Institute. · Geisinger Health System

Credentials: · · · · ·

History

Geisinger Cancer Institute. Center · Geisinger Health System
Present

Hematology and Medical Oncology
2004–2007
Internal Medicine
2001–2004
University of Pittsburgh School of Medicine
1997–2001

Research

Sarcopenia associated with chemotherapy and targeted agents for cancer therapy
Review · Annals of Palliative Medicine · 2019 · 132 citations
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after…
The Lancet Oncology · 2023 · 101 citations
Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma…
Melanoma Research · 2004 · 50 citations

Mellar Davis
6 papers
CF
Carlos Fernandez
2 papers
Corey Langer
2 papers
Glen Digwood
2 papers
HE
Halle Ellison
2 papers
Zankhana Mehta
2 papers
Anand Mahadevan
1 paper
Atom Sarkar
1 paper
Cameron Brimley
1 paper · 1 as a resident
Caroline Chiles
1 paper
Christian Adonizio
1 paper
Christian Rolfo
1 paper

Grants

Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)
National Cancer Institute · UG1
Contact PI · $15M · Geisinger Clinic
2014–2027

Clinical trials

Evaluating the Cologuard Test for Use in Lynch Syndrome
Principal investigator · Withdrawn
Geisinger Clinic
2021–2022
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Site PI · Recruiting · Phase 3
Canadian Cancer Trials Group
2025–2031
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2024–2028
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2024–2028